
Karl E. Group
Examiner (ID: 13624, Phone: (571)272-1368 , Office: P/1731 )
| Most Active Art Unit | 1731 |
| Art Unit(s) | 1731, 1755, 2899, 1108, 1793 |
| Total Applications | 4063 |
| Issued Applications | 3169 |
| Pending Applications | 125 |
| Abandoned Applications | 770 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 18/730629 | CHIMERIC POLYPEPTIDES | Jul 18, 2024 | Pending |
Array
(
[id] => 19402005
[patent_doc_number] => 20240285516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITIONS COMPRISING PROBIOTIC AND POSTBIOTIC STRAINS OF BACTERIA
[patent_app_type] => utility
[patent_app_number] => 18/652326
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652326
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652326 | COMPOSITIONS COMPRISING PROBIOTIC AND POSTBIOTIC STRAINS OF BACTERIA | Apr 30, 2024 | Pending |
Array
(
[id] => 19529502
[patent_doc_number] => 20240353404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
[patent_app_type] => utility
[patent_app_number] => 18/634194
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634194
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/634194 | METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY | Apr 11, 2024 | Pending |
Array
(
[id] => 19745690
[patent_doc_number] => 20250034255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/600262
[patent_app_country] => US
[patent_app_date] => 2024-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600262
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/600262 | COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER | Mar 7, 2024 | Pending |
Array
(
[id] => 19541768
[patent_doc_number] => 20240358804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/397180
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397180 | VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES | Dec 26, 2023 | Pending |
Array
(
[id] => 19262771
[patent_doc_number] => 20240206466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS, AND IMMOBILIZING BACILLUS SPORES ON PLANTS
[patent_app_type] => utility
[patent_app_number] => 18/392771
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18392771
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/392771 | FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS, AND IMMOBILIZING BACILLUS SPORES ON PLANTS | Dec 20, 2023 | Pending |
Array
(
[id] => 19032381
[patent_doc_number] => 20240082196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMBINED USE OF UBENIMEX AND IMMUNE CHECKPOINT INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/519225
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18519225
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/519225 | COMBINED USE OF UBENIMEX AND IMMUNE CHECKPOINT INHIBITOR | Nov 26, 2023 | Pending |
Array
(
[id] => 19157734
[patent_doc_number] => 20240150441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/500684
[patent_app_country] => US
[patent_app_date] => 2023-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18500684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/500684 | MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND VARIANTS | Nov 1, 2023 | Pending |
Array
(
[id] => 19800583
[patent_doc_number] => 20250066508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => ANTI-MASP-2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/722252
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722252 | ANTI-MASP-2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Dec 20, 2022 | Pending |
Array
(
[id] => 19785596
[patent_doc_number] => 20250059275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => TIGIT ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/721114
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721114
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721114 | TIGIT ANTIBODIES AND USES THEREOF | Dec 14, 2022 | Pending |
Array
(
[id] => 19684063
[patent_doc_number] => 20250002608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 18/709750
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18709750
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/709750 | TREATMENT OF PAIN | Nov 13, 2022 | Pending |
Array
(
[id] => 19571882
[patent_doc_number] => 20240376174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => Heterohexameric Fusion Constructs for Protein Expression in Cyanobacteria
[patent_app_type] => utility
[patent_app_number] => 18/688962
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18688962
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/688962 | Heterohexameric Fusion Constructs for Protein Expression in Cyanobacteria | Sep 1, 2022 | Pending |
Array
(
[id] => 19556492
[patent_doc_number] => 20240368284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/688663
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18688663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/688663 | A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS | Sep 1, 2022 | Pending |
Array
(
[id] => 19528224
[patent_doc_number] => 20240352126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => A PHARMACEUTICAL FORMULATION OF IMMUNE CHECK POINT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/688170
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18688170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/688170 | A PHARMACEUTICAL FORMULATION OF IMMUNE CHECK POINT INHIBITORS | Sep 1, 2022 | Pending |
Array
(
[id] => 19479498
[patent_doc_number] => 20240327540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => ANTI-PLA2G2D CONSTRUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/293765
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 3715
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293765
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293765 | ANTI-PLA2G2D CONSTRUCTS AND USES THEREOF | Aug 2, 2022 | Pending |
Array
(
[id] => 20322497
[patent_doc_number] => 20250334585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => DIAGNOSTICS FOR PORPHYROMONAS GINGIVALIS
[patent_app_type] => utility
[patent_app_number] => 18/578684
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578684 | DIAGNOSTICS FOR PORPHYROMONAS GINGIVALIS | Jul 10, 2022 | Pending |
Array
(
[id] => 19496468
[patent_doc_number] => 20240335486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => COMPOSITION FOR REARING ORGANISM BELONGING TO ORDER DECAPODA AND COMPOSITION FOR PREVENTING OR TREATING INFECTION IN DECAPODS
[patent_app_type] => utility
[patent_app_number] => 18/576842
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18576842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/576842 | COMPOSITION FOR REARING ORGANISM BELONGING TO ORDER DECAPODA AND COMPOSITION FOR PREVENTING OR TREATING INFECTION IN DECAPODS | Jul 7, 2022 | Pending |
Array
(
[id] => 19554907
[patent_doc_number] => 20240366699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => YEAST FOR THE TREATMENT OF INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/573574
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573574 | YEAST FOR THE TREATMENT OF INFLAMMATION | Jun 28, 2022 | Pending |
Array
(
[id] => 19464205
[patent_doc_number] => 20240317874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => ANTI-OX40 MONOCLONAL ANTIBODY AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/572710
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572710 | ANTI-OX40 MONOCLONAL ANTIBODY AND METHODS OF USE THEREOF | Jun 27, 2022 | Pending |
Array
(
[id] => 19462460
[patent_doc_number] => 20240316129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => Bacteria and Herbal Extract Nutraceutical Blends for Lung Health Maintenance
[patent_app_type] => utility
[patent_app_number] => 18/570867
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570867 | Bacteria and Herbal Extract Nutraceutical Blends for Lung Health Maintenance | Jun 15, 2022 | Pending |